Company news
UroGen Pharma Ltd. news in 2019
UroGen Pharma Ltd.'s news releases, calls and decks from 2019, newest first.
UroGen Pharma Announces FDA Filing Acceptance and Priority Review of U.S. New Drug Application (NDA) for UGN-101
December 18, 2019
UroGen Pharma Reports Third Quarter 2019 Financial Results and Recent Corporate Developments
November 11, 2019
UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers
November 10, 2019
UroGen Pharma to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
November 5, 2019
UroGen Reports Positive Data from Two Important Studies: UGN-101 OLYMPUS Pivotal Trial in LG UTUC and UGN-102 Phase 2b OPTIMA II Trial in LG Bladder Cancer
September 23, 2019
UroGen To Host Investor Day on September 24, 2019 Spotlighting Clinical Development Updates and UGN-101 Launch Readiness
September 9, 2019
Decks in 2019
- Investor Day (September 2019)
Investor day · 68 slides · Sep 24, 2019